Inventor · Framingham, MA, US

Vahe Bedian

33Patents
11h-index
48Co-inventors
75Inventor score

Filing activity: Nov 8, 2002 → Nov 21, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7288251B2 Antibodies to CD40 Chemistry; Metallurgy 94 Expired
US7338660B2 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 Chemistry; Metallurgy 61 Active
US7498420B2 Antibodies to c-Met Chemistry; Metallurgy 32 Expired
US7618633B2 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Chemistry; Metallurgy 31 Active
US7563442B2 Antibodies to CD40 and methods of treating cancer and enhancing immune responses Chemistry; Metallurgy 28 Active
US7326414B2 Antibodies to M-CSF Emerging Cross-Sectional Technologies 27 Expired
US7626012B2 Nucleic acid molecules which encode antibodies that bind CD40 Chemistry; Metallurgy 27 Active
US7371378B2 Modified human IGF-IR antibodies Chemistry; Metallurgy 16 Expired
US8192738B2 Targeted antibodies directed to DLL4 Chemistry; Metallurgy 13 Active
US8119130B2 Targeted binding agents directed to KDR and uses thereof—035 Chemistry; Metallurgy 12 Active
US8562985B2 Antibodies to c-Met Chemistry; Metallurgy 11 Active
US7537762B2 Human monoclonal antibodies to activin receptor-like kinase-1 Chemistry; Metallurgy 10 Active
US8388971B2 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Chemistry; Metallurgy 10 Active
US8821869B2 Treatment methods using c-Met antibodies Chemistry; Metallurgy 9 Active
US8163280B2 Antibodies to c-Met Chemistry; Metallurgy 6 Active
US7728113B2 Methods of treating arthritic conditions with antibodies to M-CSF Emerging Cross-Sectional Technologies 5 Active
US7592430B2 Antibodies to M-CSF Emerging Cross-Sectional Technologies 5 Expired
US8507656B2 Stabilized angiopoietin-2 antibodies and uses thereof Chemistry; Metallurgy 4 Active
US8398975B2 Antibodies directed to αVβ6 and uses thereof Chemistry; Metallurgy 3 Active
US8080646B2 Human monoclonal antibodies to activin receptor-like kinase-1 Chemistry; Metallurgy 3 Active
US11548951B1 Compositions and methods for treatment of thyroid eye disease Chemistry; Metallurgy 2 Active
US8188249B2 Nucleic acid molecules encoding antibodies to M-CSF Emerging Cross-Sectional Technologies 2 Active
US9221915B2 Human monoclonal antibodies to activin receptor-like kinase-1 Chemistry; Metallurgy 1 Active
US10280219B2 Antibodies to M-CSF Emerging Cross-Sectional Technologies 1 Active
US10329345B2 Stabilized angiopoietin-2 antibodies and uses thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.